Officers: Allen Stegall - Principal, Exec. Director of Strategy; Raffi Siyahian - Principal, Exec. VP; Bob Costanza - Principal, Executive Creative Director; Jennifer Brekke - Principal, CEO
2012 Gross Income: $10 million to $15 million.
Full-time Employees: 63 (2012) 53 (2011)
BMS, Symlin; Jazz Pharmaceuticals, Prialt, Xyrem DTC; Lundbeck, Onfi, Sabril, Corporate Communications; Depomed, Zipsor; Xenoport, arbaclofen
Number of accounts gained in 2012: 4
Accounts gained: Lundbeck, Sabril; Jazz Pharmaceuticals, Xyrem DTC; Depomed, Zipsor; Xenoport, arbaclofen.
Services: Market analysis, product positioning, brand development, digital marketing services, media planning, creative concept development, tactical program development and execution.
Offices: San Diego, CA
Description: The new Sabril campaign changed physician and patient conversations about the brand. By candidly acknowledging the challenges relating to use of Sabril, we were able to disarm physicians who had previously been unable to get past these challenges, allowing them to consider and embrace the potential benefits.
Creative/Account team: Dana Callow, VP, Creative Director, Allen Stegall, Executive Director of Strategy, Principal, Kristin Cox, Account Supervisor
Why this ad special:
A concept loved by all, the frog prince was an obvious favorite of agency, brand team, sales force, and physicians. It handily paid off a novel strategy in a simple yet distinctive way, and brought smiles to the faces of those who engaged with the concept from day one.